Motoi Okada

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Top Venues

Journal of clinical medicine

Acute medicine & surgery

International journal of molecular sciences

American journal of physiology. Heart and circulatory physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Tatsuki Kuroshima, Satoshi Kawaguchi, Motoi Okada
Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy. International journal of molecular sciences 25 (9) (2024)
Bruno Levy, Michel Slama, Ines Lakbar, Julien Maizel, Hiromi Kato, Marc Leone, Motoi Okada
Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review. Journal of clinical medicine 13 (10) (2024)
Satoshi Kawaguchi, Tatsuki Kuroshima, Ryo Namba, Hiroki Satou, Riku Kashiwagi, Ai Abe, Motoi Okada
A case of repeated Kounis syndrome after anaphylactic shock: A note for disease management. Acute medicine & surgery 11 (1) (2024)
Satoshi Kawaguchi, Tatsuki Kuroshima, Ryo Namba, Hiroki Satou, Riku Kashiwagi, Ai Abe, Motoi Okada
A case of repeated Kounis syndrome after anaphylactic shock: A note for disease management. Acute medicine & surgery 11 (1) (2024)
Tatsuki Kuroshima, Satoshi Kawaguchi, Motoi Okada
Current Perspectives of Mitochondria in Sepsis-Induced Cardiomyopathy. International journal of molecular sciences 25 (9) (2024)
Bruno Levy, Michel Slama, Ines Lakbar, Julien Maizel, Hiromi Kato, Marc Leone, Motoi Okada
Landiolol for Treatment of New-Onset Atrial Fibrillation in Critical Care: A Systematic Review. Journal of clinical medicine 13 (10) (2024)
Ryosuke Asakura, Tatsuki Kuroshima, Naohiro Kokita, Motoi Okada
A case of COVID-19-associated fulminant myocarditis successfully treated with mechanical circulatory support. Clinical case reports 10 (9) (2022)
Satoshi Kawaguchi, Motoi Okada
Cardiac Metabolism in Sepsis. Metabolites 11 (12) (2021)
Satoshi Kawaguchi, Motoi Okada, Eriko Ijiri, Daisuke Koga, Tsuyoshi Watanabe, Kentaro Hayashi, Yuta Kashiwagi, Satoshi Fujita, Naoyuki Hasebe
β3-Adrenergic receptor blockade reduces mortality in endotoxin-induced heart failure by suppressing induced nitric oxide synthase and saving cardiac metabolism. American journal of physiology. Heart and circulatory physiology 318 (2) (2019)